Paul Schloesser is a Business Operations Assistant at Endpoints News. He focuses on the biotechnology and pharmaceutical industries, with a keen interest in drug development, clinical trials, and healthcare. Paul has been featured in Endpoints News, where he contributes insights into these critical areas of medicine and innovation.
Preston's Summary
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Geo Focus
United States (National)
Coverage Attributes:
Beta
Press Release:
37
%
Private Sector Announcements:
16
%
Government Announcement:
15
%
Cites Data:
13
%
Legal Policy Regulation:
10
%
Themes Covered:
Not enough data
Pitching Insights
Paul Schloesser's articles predominantly focus on the healthcare and pharmaceutical industry, with a strong emphasis on biotechnology. His coverage includes press releases, private sector announcements, government announcements, and data citations.
To effectively reach out to Paul, consider providing insights into new developments in drug development processes or clinical trials within the biotechnology and pharmaceutical sectors. Emphasize any unique data or evidence that supports your pitch as he frequently cites data in his articles.
Given his extensive coverage of private sector and government announcements alongside press releases, it would be beneficial to offer exclusive information about significant company milestones or regulatory approvals within these industries.
This information evolves through artificial intelligence and human feedback. Improve this profile .
